Free Trial

SCYNEXIS (SCYX) Stock Forecast & Price Target

$1.51
-0.02 (-1.31%)
(As of 10/15/2024 ET)

SCYNEXIS - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
1

Based on 1 Wall Street analysts who have issued ratings for SCYNEXIS in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for SCYX.

Consensus Price Target

N/A

Get the Latest News and Ratings for SCYX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for SCYNEXIS and its competitors.

Sign Up

SCYX Analyst Ratings Over Time

TypeCurrent Forecast
10/16/23 to 10/15/24
1 Month Ago
9/16/23 to 9/15/24
3 Months Ago
7/18/23 to 7/17/24
1 Year Ago
10/16/22 to 10/16/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/A$15.00$11.40
Forecasted UpsideN/AN/A591.24% Upside448.08% Upside
Consensus Rating
Buy
Buy
Buy
Buy

SCYX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SCYX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

SCYNEXIS Stock vs. The Competition

TypeSCYNEXISMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.79
2.50
Consensus RatingBuyModerate BuyHold
Predicted UpsideN/A10,351.18% Upside6.70% Upside
News Sentiment Rating
Positive News

See Recent SCYX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/1/2024Cantor Fitzgerald
3 of 5 stars
L. Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight
4/3/2023Guggenheim
3 of 5 stars
 Boost TargetBuy$8.00 ➝ $9.00+181.25%
4/3/2023LADENBURG THALM/SH SH
4 of 5 stars
 Reiterated RatingBuy$15.00+413.70%
3/30/2023Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$7.00 ➝ $10.00+240.14%
10/21/2022Brookline Capital Acquisition
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$8.00+220.00%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:57 PM ET.


SCYX Forecast - Frequently Asked Questions

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SCYNEXIS in the last year. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SCYX shares.

According to analysts, SCYNEXIS's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like SCYNEXIS more than other "medical" companies. The consensus rating for SCYNEXIS is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SCYX compares to other companies.


This page (NASDAQ:SCYX) was last updated on 10/15/2024 by MarketBeat.com Staff
From Our Partners